asymmetric henry and aza-henry reactions 010604...asymmetric henry and aza-henry reactions d.j....

46
Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III

Upload: others

Post on 24-Jan-2020

11 views

Category:

Documents


0 download

TRANSCRIPT

Page 1: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Asymmetric Henry and Aza-Henry Reactions

D.J. Osborn III

Page 2: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Drugs and Sugars

HO

HO

HN

OH

OHArbutamine

Coronary Heart Disease

HCl

O

O

HN

OH

NSO2

AmprenavirHIV Protease Inhibitor

NH2

O

ON

OH

HO

H

H

Lycorine

HN

MethylamphetamineADHD

O

O

HN

MDMASeratonin Release

MescalineSeratonin Release

NH2MeO

MeO

MeO

OH

OH

HO

HO OH

OH

Substituted Inositols

Page 3: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Recent Approaches to Selectivity• Chiral Ligands

– Shibasaki's Bimetallic Lanthanide/Lithium System– Trost's Zn/Chiral Phenol System– Lin's Zn/β-Amino Alcohol System– Jorgensens's Cu/BOX System– Evans' Cu/BOX System

• Chiral Quaternary Ammonium Salts– Corey– Maruoka

• Chiral Organic Catalysts– Takemoto's Chiral Thioureas– Johnston's Chiral Proton

• Dendrizymes– Smith – Cossio

Page 4: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Henry Reaction – General Mechanism

R

NO2HH

pKa = ~9

R

HH

N OO

:B

PlanarNitronate

R

N OO

H N ORH O

:B

BH

Control Nitronate Geometry and Reactivity to gain Selectivity

PyramidalNitronate

H

OH

NO O

R'

NO

O

R' H

O H

HB

- B:R

NO

O

R' H

HHOR

R

Control Approach and TS for Selectivity

Page 5: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Henry Reaction – Selectivity

RL

RMRS

OH

H

OH

NO O

R'

NO

O

R' H

O H

HB

- B:R

NO

O

R' H

HHOR

R

Control Approach and TS for Selectivity

N

O

MOH

O

RH

N

O

MOH

O

RR

R

H

N

O

MOH

O

RH

N

O

MOH

O

RR

R

H

syn

antiH

CO Me

H

H

H

MeH

OH

Re face

Si face

O2N

CH2

NO2

HC

O Me

H

H

H

RH

OH

Re face

Si face

CH2

NO2

O2N

Page 6: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Henry Reaction – General Mechanism

H

OH

NO O

R'

NO

O

R' H

O H

HB

- B:R

NO

O

R' H

HHOR

R

Control Approach and TS for Selectivity

pKa = ~9

R

HH

N OO

:B

PlanarNitronate

R

N OO

H N ORH O

:B

BH

Control Nitronate Geometry and Reactivity to gain Selectivity

PyramidalNitronate

R

NO2HH

RN

O

OHO

R1 H

B:

RN

O

O

R'OH BH++

Elimination can be a problem

Page 7: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Aza-Henry Reaction – General Mechanism

H

N

R'

NO2HH

B

R'

NH H N

O

O

R'

- BHO

O

+R

PG

+ BH

PlanarNitronate

PyramidalNitronate

R H

N

H

N

R'

NO

OHB

RN

O

OHN

R1H

PG

PGH

H

H

PG

- :BH

NO O

R'

Page 8: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Bimetallic - Shibasaki

Sasai, H.; Tokunga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem., 1995, 60, 7388

Aldehyde Nitroalkane Time (h) Temp. (oC) Yield (%) Syn / Anti ee (%)

H

ONO2

75 -20 70 89:11 93

NO2138 -40 85 93:7 95

HO

NO2

111 -40 97 92:8 97

H

O

HO

NO2

93 -40 96 92:8 95

H

O

R'+ Cat. (3.3 mol%)

THFR''

NO2

R'R''

NO2

OH

+R'

R''

OH

NO2

OH

OH

C

C

C

C

Et3Si

Et3Si

(R)-6,6'-Disubstituted BINOL

Best Selectivity

Page 9: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Bimetallic - Shibasaki

Sasai, H.; Tokunga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem., 1995, 60, 7388

LaOO O

O

O

O

Li

Li

Li

R

R

R

R

R

R

H

O

R

R'

N

H H

O

R

H

N

R' R

H

OR'

N

H R

H

O

H

N

R' H

O

R

O

O O

O

O

O

O

O

H

R'

N

H

O

R

R'

H

N

O

O

O

O

La

Li

La

Li

La La

Li Li

Li Li

syn anti

anti

anti

syn

syn

Steric Repulsions are Minimized

Page 10: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Bimetallic - Shibasaki

Sasai, H.; Tokunga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem., 1995, 60, 7388

Nu

O H

HC

O R

H

H

HC

O R

H

H

H

R HNu

OH

H

R H

Nu

OH

Nu

O HH

HR

H

HR

Nu-

Nu-Re face

Si face

Re face

Si face

LaOO O

O

O

O

Li

Li

Li

R

R

R

R

R

R

Page 11: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Bimetallic - Shibasaki

Sasai, H.; Tokunga, T.; Watanabe, S.; Suzuki, T.; Itoh, N.; Shibasaki, M. J. Org. Chem., 1995, 60, 7388

LaOO O

O

O

O

Li

Li

Li

R

R

R

R

R

R

LaOOO

O

O

O

Li

Li

Li

LaO

OOO

O

O

Li

LiLi

R'R

NO2

OH

R

NO2

OHN

O

R LaO

OOO

O

O

Li

Li LiO

H

NO

R

OH

R'

R'CHO

Page 12: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Trost

Trost, B. M.; Yeh, V. S. C. Angew. Chem.-Int. Edit. 2002, 41, 861

H

O+ CH3NO2

2 (mol%)4-A MS

solvent, T,24 h

OH

NO2

10

10

10

10

10

2

2

10

6

5

5

5

5

5

5

5

2.5

5

5

-20

-20

-20

-20

-20

-78 then -20

-78 then -20

-78 then -20

THF:dioxane, 4:1

69

68

68

75

20

17

75

44

70

78

85

57

51

55

86

85

85

86

CH3NO2(equiv)

Catalyst(mol%)

T (oC) Solvent % Yield % ee

THF

THF

toluene

THF

THF

THF

Et2O

CH2Cl2

CH3

N N

OPhPh

O PhPh

O

Zn Zn

Et

2

Page 13: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Trost

Trost, B. M.; Yeh, V. S. C. Angew. Chem.-Int. Edit. 2002, 41, 861

CH3

N N

OPhPh

O PhPh

O

Zn Zn

Et

2

R H

OCH3NO2+

2 (5 mol%), ZnEt2 (2 equiv.)

THF, -78 then -35 oC24 h

RNO2

OH

R Yield (%) ee (%)

Ph

BnO

75

59

58

88

90

56

85

84

88

93

92

86

84 87

Page 14: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Trost

Trost, B. M.; Yeh, V. S. C. Angew. Chem.-Int. Edit. 2002, 41, 861

CH3

N N

OPhPh

O PhPh

O

Zn Zn

Et

2

R H

OCH3NO2+

2 (5 mol%), ZnEt2 (2 equiv.)

THF, -78 then -35 oC24 h

RNO2

OH

R Yield (%) ee (%)

75

71

69

79

91

93

78

90

MeO

MeO

N

Boc

Page 15: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Trost

Trost, B. M.; Yeh, V. S. C. Angew. Chem.-Int. Edit. 2002, 41, 861

CH3

N N

OPhPh

O PhPh

O

Zn Zn

Et

CH3

N N

OPhPh

O PhPh

O

Zn Zn

O

NO

CH3NO2 CH3CH3

CH3

N N

OPhPh

O PhPh

O

Zn Zn

O

NO

O H

R

CH3

N N

OPhPh

O PhPh

OZn Zn

ONO2

RH

CH3

N N

OPhPh

O PhPh

O

Zn Zn

O

NO

ONO2

RH

HONO2

RH

CH3NO2

R H

O

Page 16: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Lin

Zhong, Y. W.; Tian, P.; Lin, G. Q. Tetrahedron: Asymmetry 2004, 15, 771

H

H

4a

OH

NH

Ph

OH

HN Ph

H

H OH HN Ph

NH

PhHO

4b

H

H OH HN Ph

NH

PhHO

5

5 mol% Ligand, ZnEt2

THF

Time Yield (%) ee (%)

10

10

7

7

9

8

87

81

93

77

59

90

38

12

25

46

38

52

Ligand : ZnEt2

1 : 3

1 : 3

1 : 5

1 : 2

1 : 1

1 : 2

Ligand

4b

5

4b

4b

4b

4a

8 75 591 : 24b

CH3NO2+

Temperature

0 oC

0 oC

0 oC

0 oC

0 oC

-25 oC

-25 oC

O

H

OH

NO2

Page 17: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Lin

Zhong, Y. W.; Tian, P.; Lin, G. Q. Tetrahedron: Asymmetry 2004, 15, 771

R H

OCH3NO2+

4a (10 mol%), ZnEt2 (2 equiv.)

THF, -25 oC RNO2

OH

R Time Yield (%) ee (%)

Ph

Ph

8

11

10

12

20

20

90

74

90

82

50

40

52

37

66

67

69

74

H

H

4a

OH

NH

Ph

OH

HN Ph

Page 18: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Zinc Based - Lin

Zhong, Y. W.; Tian, P.; Lin, G. Q. Tetrahedron: Asymmetry 2004, 15, 771

R Time Yield (%) ee (%)

MeO

OMe

8

36

42

23

80

81

73

75

33

25

21

49

R H

OCH3NO2+

4a (10 mol%), ZnEt2 (2 equiv.)

THF, -25 oC RNO2

OH

H

H

4a

OH

NH

Ph

OH

HN Ph

Page 19: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

N

O

N

O

tBu tBuMXn

N

O

N

O

Ph

Ph Ph

PhMXn

N

O

N

O

Ph PhMXn

N

O

N

O

Ph

Ph Ph

PhMXn

N

O

N

O

Ph PhMXn

P

PCuClO4

TolTol

TolTol

Page 20: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Knudsen, K. R.; Risgaarc, T.; Nishiwaki, N.; Gothelf, K. V..; Jorgensen, K. A. J. Am. Chem. Soc., 2001, 123, 5843

NTMSO O

R'

NPMP

CO2Et

+Cat. (20 mol%)

-100 oCO2N

CO2Et

R'

HN

R' Catalyst % Yield % ee erythro erythro:threo Configuration(C2,C3)

EtEtEt

Et

Et

Et

Et

Et

EtEtEtMePentylBn

(R)-4(R)-5a(R)-5b

(S)-6a

(S)-6b

(S)-6c

(S)-6d

(4R,5S)-7a(4R,5S)-7b(4R,5S)-7c(4R,5S)-7d

(S)-6a(4R,5S)-7d(4R,5S)-7a

999958

90

63

67

92

52

685494678793

161256

90

56

89

70

96

972695

>988388

1:311:17:1

3:1

5:1

18:1

6:1

6:1

10:19:1

25:15:

39:132:

(R,R)(S,S)(R,R)

(S,S)

(S,S)

(S,S)

(S,S)

(R,R)

(R,R)(R,R)(R,R)(S,S)(R,R)(R,R)

PMP

N

O

N

O

5a: MXn = Cu(I)ClO45b: MXn = Cu(I)(OTf)2

tBu tBuMXn

N

O

N

O

6a: MXn = Cu(I)ClO46b: MXn = Cu(I)PF66c: MXn = Cu(I)(OTf)26d: MXn = Cu(I)(SbF6)2

Ph PhMXn

N

O

N

O

7a: MXn = Cu(I)ClO47b: MXn = Cu(I)PF67c: MXn = Cu(I)(OTf)27d: MXn = Cu(I)(SbF6)2

Ph

Ph Ph

PhMXn

P

P

4 (R)-Tol-BINAP

CuClO4

TolTol

TolTol

Page 21: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Nishiwaki, N.; Knudsen, K. R.; Gothelf, K. V..; Jorgensen, K. A. Angew. Chem. Int. Ed., 2001, 40, 2992

N

O

N

O

(S) - 4

tBu tBuMXn

N

O

N

O

Ph

Ph Ph

PhMXn

(4R, 5S) - 5

N

O

N

O

(R) - 6

Ph PhMXn

a : MXn = Cu(I)(OTf)2b : MXn = Cu(I)(SbF6)2c : MXn = Cu(I)Br2

NTMSO O

Et

NPMP

CO2Et

+Cat. , base O2N

CO2Et

R'

HN

Time (days)Catalyst % Conv. ee (syn / anti)syn / anti

1

1

1

1

1

1

1

1

1

1

1

7

1

5

4a

5a

6a

6a

6a

6b

6c

6a

6a

6a

6a

6a

6a

6a

862

85

14

26

85

69

83

40

80

43

83

86

87

87 / 70

2 / 2

94 / 85

97 / 90

97 / 83

26 / 21

93 / 86

95 / 95

97 / 91

72 / 76

96 / 86

91 / 85

95 / 79

97 / 87

95 / 5

84 / 16

92 / 8

96 / 4

97 / 3

60 / 40

95 / 5

82 / 18

95 / 5

54 / 46

95 / 5

92 / 8

93 / 7

95 / 5

PMP

Solvent

CH2Cl2CH2Cl2CH2Cl2

THF

Et2O

CH2Cl2

CH2Cl2

CH2Cl2

CH2Cl2CH2Cl2

CH2Cl2CH2Cl2CH2Cl2

CH2Cl2

Mol %

20

20

20

20

20

20

20

20

20

20

20

10

20

20

Room Temperature

Page 22: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Nishiwaki, N.; Knudsen, K. R.; Gothelf, K. V..; Jorgensen, K. A. Angew. Chem. Int. Ed., 2001, 40, 2992

NTMSO O

R

NPMP

CO2Et

+(R)-6a O2N

CO2Et

R'

HN

Catalyst % Yield ee (syn / anti)dr syn / anti

Et

H

Me

Me

Pentyl

Bn

Ph

81

38

61

50

52

80

59

97 / 87

87

97 / 95

99 / 98

97 / 89

95 / 88

74 / 77

95 / 5

70 / 30

73 / 27

93 / 7

95 / 5

55 / 45

PMP

Temperature (oC)

0rt

rt

0

rt

rt

rt

Et3N, rt

N

O

N

O

Ph PhCu

TfO OTf

(R) - 6a

Page 23: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Risgaard, T.; Gothelf, K. V.; Jorgensen, K. A. Org. Biomol. Chem. 2003, 1, 153

NTMSO O

R' R''

O

H+

1) 6c-Cu(OTf)2 (20 mol%), TBAT, rt2) 4, Pyridine, CH2Cl2, rt

R'O

NO2R''

OPh

CF3MeO

R' R'' % Yield dr threo:erythro %ee threo

Et

Et

Et

Et

Et

Et

Pentyl

Et

Ph

p-MeOC6H4

p-NCC6H4

p-O2NC6H4

m-O2NC6H4

2-Np

Ph

(E)-Ph-CH=CH

76

34

47

63

67

34

81

44

5 : 1

3 : 1

>10 : 1

>10 : 1

>10 : 1

2.5 : 1

3 : 1

>10 : 1

65

59

40

50

45

60

43

45Cl

OPh

CF3MeO

4

TBATtetrabutylammonium

triphenylsilyldifluorosilicate

(Bu)4N Si(F)2(Ph)3

N

O

N

O

6c

Ph

Ph Ph

PhMXn

Page 24: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Nishiwaki, N.; Knudsen, K. R.; Gothelf, K. V..; Jorgensen, K. A. Angew. Chem. Int. Ed., 2001, 40, 2992

Mechanism proposed by Jorgensen

NO

N

O

MeMe

CuN

O

PG

OEt

NO

N

O

MeMe

Cu O N

N

O OEt

O

R

HPG

NO

N

O

MeMe

CuO N

N

O OEt

OR

HPG

NPG

OEt

O

-2 TfO

NO2EtO

O

HN

R

PMP

R

NO2

NEt3HNEt3

NPG

OEt

O

NO

N

O

MeMe

CuOTf

OTf

Tetrahedral Cu ?

Page 25: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Jorgensen

Nishiwaki, N.; Knudsen, K. R.; Gothelf, K. V..; Jorgensen, K. A. Angew. Chem. Int. Ed., 2001, 40, 2992

My proposed alteration to Jorgensen’s Mechanism

NO

N

O

MeMe

CuN

O

PG

OEt

NO

N

O

MeMe

Cu

O N

N

O OEt

R

HPG

NO

N

O

MeMe

CuO N

N

O OEt

OR

HPG

NPG

OEt

O

-2 TfO

NO2EtO

O

HN

R

PMP

R

NO2

NEt3HNEt3

NPG

OEt

O

NO

N

O

MeMe

CuOTf

OTf

O

Should be Planar

Page 26: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Evans

Evans, D. A.; Seidel, D.; Rueping, M.; Lam, H. W.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2003, 125, 12692

N

O

N

O

L: bis(oxazoline) ligand

R' Time (h) Yield (%) ee (%)

H

O

R'+ [(L)Cu](OAc)2

EtOH, rtCH3NO2

R'NO2

OH

Ph2-MeC6H4

2-MeOC6H4

2-NOC6H4

2-ClC6H4

1-naphthyl4-FC6H4

4-ClC6H4

4-PhC6H4PhCH2CH2

i-Bu

i-Prn-Bucyclohexyl

i-Bu

2242274

15154521202448

484848

96

7672918688667073708186

868795

83

9493938991879290919092

949393

94

(R)

Page 27: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Copper Based - Evans

Evans, D. A.; Seidel, D.; Rueping, M.; Lam, H. W.; Shaw, J. T.; Downey, C. W. J. Am. Chem. Soc. 2003, 125, 12692

ON

CH3

O

XCuXL

L

ON

O

CH3

CuLL X

O

NCH2O

-HX

RCHO

CuLL X

O

NO

O

R

+HX

O

NO

OH

R

XCuXL

L

Cu CuLLL2

CuLL

E

Nu

CuLL Nu

E

HighestReactivity

IntermediateReactivity

LowestReactivity

CuLL

Nu

E

CuLL OAc

O

O CuLL O

O

OAc

H

R

NO

H

HCu

LL OAc

O

O

H

R

N HH

O

H R

NO

H

H

Favored by Evans

Page 28: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Quaternary Ammonium Salts - Corey

Corey, E. J. and Zhang, Fu-Yao, Angew. Chem. Int. Ed., 1999, 38, 1931

Bn2NH

O

tBuOCONH H

OtBuOCONH NO2

OH

Bn2N NO2

OH(10 mol%)

12.5 eq. KFTHF, -10 oC, 6h

86%

(10 mol%)

10 eq. KFCH2Cl2, -10 oC, 12h

88%

Bn2N NO2

OH

tBuOCONH NO2

OH

+

+

+

+

CH3NO2

CH3NO2

9:1

17:1

NO

N

F

NO

N

Br

Page 29: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Quaternary Ammonium Salts - Corey

Corey, E. J. and Zhang, Fu-Yao, Angew. Chem. Int. Ed., 1999, 38, 1931

gives syn products gives anti prodcuts

Nu-Nu-

Page 30: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Quaternary Ammonium Salts - Maruoka

Ooi, T.; Doda, K.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 2054

N

Ar

Ar

HF2

(S,S)-1

CF3

CF3

F3C CF3

CF3

CF3

Ar =

1a 1b

ON

OSiR3

R1

H R2

O

+(S,S) - 1b (2 mol%)

THF-98 to -78 oC

1 N HCl

0 oC R1 R2

OH

NO2

Me

EtBnO(CH2)2

Et3

Me3

tBuMe2

Me3

Ph

p-MePh

p-FPh

β-Np

Ph

Ph

2

34

3

5

4

4

4

4

4

83 (74:26)

92 (92:8)90 (90:10)

94 (85:15)

45 (57:43)

92 (94:6)

94 (83:17)

88 (92:8)

94 (90:10)

70 (87:13)

33 (1R,2S)

95 (1R,2S)93 (1R,2S)

92 (1R,1S)

11 (1R,2S)

97

90

93

91

91

%ee(config.)

% Yield(anti/syn)

Time (h)R2R3R1

Page 31: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Quaternary Ammonium Salts - Maruoka

Ooi, T.; Doda, K.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 2054

Favored Disfavored

Page 32: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Quaternary Ammonium Salts - Maruoka

Ooi, T.; Doda, K.; Maruoka, K. J. Am. Chem. Soc. 2003, 125, 2054

R2

O HO

O

N

H

R1 N

syn

H

O R2O

O

N

H

R1 N

anti

Page 33: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Substituted Thioureas - Takemoto

Okino, T.; Nakamura, S.; Furukawa, T.; Takemoto, Y. Org. Lett. 2004, 6, 625

Ar

NP(O)Ph2

ArNO2

R

HNP(O)Ph2

R

NO2+

1b (0.1 equiv.)

CH2Cl2, rt

Ar R % Yield %ee (dr)

Ph

4-MePh

4-ClPh

2-napth

2-furyl

2-pyridyl

2-thienyl

Cinnamyl

Ph

H

H

H

H

H

H

H

H

Me

87

72

76

78

85

91

57

68

83

67

63

67

70

76

68

64

65

67 (73:27)

F3C

CF3

NH

NH

S

N

1b

Page 34: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Substituted Thioureas - Takemoto

Okino, T.; Nakamura, S.; Furukawa, T.; Takemoto, Y. Org. Lett. 2004, 6, 625

N N

S

N

ON

O

R HH

H HN N

S

N

ON

O

R

H H

H

H

3.416 A

Page 35: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Chiral Proton Catalyst - Johnston

Nugent, B. M.; Yoder, R. A.; Johnston, J. N. J. Am. Chem. Soc. 2004, 126, 3418

N N

N NHH

H H

H OTf

Catalyst

Yield (%) %eedrR''R'

H

p-NO2

m-NO2

H

p-CF3O

p-Cl

m-NO2

o-NO2

p-CF3

p-NO2

H

CH3

CH3

CH3

CH3

CH3

H

H

CH3

CH3

57

61

65

69

53

59

51

62

50

60

_

_

_

14:1

19:1

17:1

11:1

7:1

19:1

7:1

60

82

95

59

81

82

89

82

84

90

H

NBoc

R' R''

NO2

HNBoc

R'

NO2

R''+

-20 oC

Cat. (10 mol%)

Page 36: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Smith

Davis, A. V.; Driffield, M.; Smith, D. K. Org. Lett. 2001, 3, 3075

N

HN

NHNH

O

O

NHBoc

BocHN O NHBoc

NHBoc

NHBocBocHN

G1(N:)

N

HN

NHNH

O

O

NH

HN O HN

HN

NHHN

O

BocHNNHBoc

O

NHBoc

BocHN

O

BocHN

BocHN

ONHBoc

OBocHN

BocHN

BocHN

G2(N:)

Page 37: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Smith

Davis, A. V.; Driffield, M.; Smith, D. K. Org. Lett. 2001, 3, 3075

N

HN

NHNH

O

O

NH

HN O HN

HN

NHHN

O

BocHNNHBoc

O

NHBoc

BocHN

O

BocHN

BocHN

ONHBoc

OBocHN

BocHN

BocHN

G2(N:)

N

HN

NHNH

O

O

NHBoc

BocHN O NHBoc

NHBoc

NHBocBocHN

G1(N:)

H

O+

Cat. (15 mol%)

THF

OH

Time Conversion (%) syn : anti

48

1

1

0.5

48

24

none

85

95

91

92

94

57 : 43

56 : 44

55 : 45

42 : 58

54 : 46

Catalyst

none

DIPEA

NEt3 + acetamide

G1(N:)

G2(N:)

NEt3

(10 mol%)

NO2

NO2

OH

NO2O2N O2N O2N

+

Page 38: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Cossio

Zubia, A.; Cossio, F. P.; Morao, L. A.; Rieumont, M.; Lopez, X. J. Am. Chem. Soc. 2004, 126, 5243

N

O

O O

A0

N

O

O O

MA2

O

OO

OO

O

MA1

N

O

O O

O

OO

Page 39: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Cossio

Zubia, A.; Cossio, F. P.; Morao, L. A.; Rieumont, M.; Lopez, X. J. Am. Chem. Soc. 2004, 126, 5243

N

O

O O

DA1

O O

O

O

O

O

DA2

N

O

O O

O O

O

O

O

O

O

oO

O

O

O

O O O O

O

O

Page 40: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Cossio

Zubia, A.; Cossio, F. P.; Morao, L. A.; Rieumont, M.; Lopez, X. J. Am. Chem. Soc. 2004, 126, 5243

TA2

N

O

O O

O O

O

O

O

O

O

O O

O

OO

OO

O

OO

O

OO

O

O

OO

OO

OOO

O

OO

O

O

OO

N

O

O O

O O

O

O

O

O

O

O O

TA1

Page 41: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Dendrizyme Approach - Cossio

Zubia, A.; Cossio, F. P.; Morao, L. A.; Rieumont, M.; Lopez, X. J. Am. Chem. Soc. 2004, 126, 5243

H

O+

Cat. (15 mol%)

THF

OH

kobs (10-4s-1) syn : anti

12.11

10.85

5.53

8.25

3.70

69 : 31

67 : 33

68 : 32

66 : 34

Catalyst

A0

MA2

DA1

DA2

MA1

NO2

NO2

OH

NO2

+OH

66 : 34

1.89

1.03

67 : 33

72 : 28

TA1

TA2

Increasing Bulkiness

N

O

O O

A0

TA2

N

O

O O

O O

O

O

O

O

O

O O

O

OO

OO

O

OO

O

OO

O

O

OO

OO

OOO

O

OO

O

O

OO

Page 42: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

C-13 Side-Chain of Taxol

Borah, J. C.; Gogoi, S.; Boruwa, J.; Kalita, B.; Barua, N. C. Tetrahedron Lett. 2004, 45, 3689

Ph

NO2

OBn+ Ph OBn

NO2

OH

(2R, 3S)

H

O

La-(R)-BINOL (10 mol%)

THF, -50 oC,80% Yield

Ph OBn

NO2

OH

(2R, 3S)

Ph OBn

NO2

OAc

Ac2O, Pyridine

93% YieldPh OH

NH2

OAc

10% Pd/CEtOH, H2, rt80% Yield

98% ee

Ph OH

NH2

OAc

Ph OH

NH2

OAc

O

Glacial Acetic AcidWater, 5 oC82% Yield

CrO3

96% ee

Ph OH

NH

OAc

O1) Benzoyl Chloride, Et3N, 0 oC

2) Et2NMe-H2O

O

Ph

Page 43: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Inositol Derivatives

Soengas, R. G.; Estevez, J. C.; Estevez, R. J. Org. Lett. 2003, 5, 4457

O

BnO

BnO

OH

OH

OBn

O2N

O

BnO

HO

OH

O2NO

BnO

H

O O2N OH

TBAFTHF

rt, 10 h75% Yield

O

O

O

O

O

BnO

BnO

OH

OH

OH

OBn

OBn

O2N

BnO

HO OH

CHO

OBn

OBn

O2N

BnO

HO OH

OBn

O2N

2% aq. NaCO3H

MeOHrt. 14 h

53% yield

Page 44: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Inositol Derivatives

Soengas, R. G.; Estevez, J. C.; Estevez, R. J. Org. Lett. 2003, 5, 4457

O

BnO

BnO

OH

OH

OH

OBn

OBn

O2N

BnO

HO OH

CHO

OBn

OBn

O2N

BnO

HO OH

OBn

O2N

CHO

OBn

NO2

BnO

HO OH

O

BnO

BnO

OH

OH

OBn

O2N

+

OH

OBn

NO2

BnO

HO OH

OBnOBn

Page 45: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Conclusions• Chiral Ligands

– Shibasaki's Bimetallic Lanthanide/Lithium System– Trost's Zn/Chiral Phenol System– Lin's Zn/ System– Jorgensens's Cu/BOX System– Evans' Cu/BOX System

• Chiral Quaternary Ammonium Salts– Corey– Maruoka

• Chiral Organic Catalysts– Takemoto's Chiral Thioureas– Johnston's Chiral Proton

• Dendrizymes– Smith– Cossio

Page 46: Asymmetric Henry and Aza-Henry Reactions 010604...Asymmetric Henry and Aza-Henry Reactions D.J. Osborn III Drugs and Sugars HO HO H N OH OH Arbutamine Coronary Heart Disease HCl O

Acknowledgements• Dr. Borhan• Dr. Baker• Dr. Ruby N. Ghosh• Jamie Dunn• Baker Group